| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| forgiftning med diagnostisk farvestof |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| accidentel forgiftning med diagnostisk farvestof |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| tilsigtet forgiftning med diagnostisk farvestof |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| forgiftning med diagnostisk farvestof, uvist med hvilken hensigt |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye adverse reaction |
Causative agent |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| allergi over for diagnostisk farvestof |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| proparacainhydrochlorid + fluoresceinnatrium 0,5 %/0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium-strip, 1 mg, til oftalmologisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 10 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing rose bengal (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| rose bengal 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| benoxinathydrochlorid + fluoresceinnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| lidokainhydrochlorid 4 % + fluoresceinnatrium 0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| benoxinathydrochlorid + fluoresceinnatrium 0,3 %/0,125 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| diagnostisk farvestof |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Methylthioninium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| metylenblåt 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing lissamine green B stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| strip med lissamingrønt til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing trypan blue stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| 0,06 opløsning med trypanblåt til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 200 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Product containing tolonium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Diagnostic dye introduction |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Methylthioninium chloride 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein + proparacaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| diagnostiske øjenpræparater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Opulets Fluorescein single-use eye drops 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| metylenblåt 1 % injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| metylenblåt 1 % injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| indigotindisulfonatnatriumprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| indigotindisulfonatnatrium 40 mg injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Opulets Fluorescein |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| benoxinathydrochlorid + fluoresceinnatrium 0,4 %/0,25 % opløsning til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 0,6 mg strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| 1,3 mg strip med rose bengal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 10 % intraokulær injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 10 % intraokulær injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 25 % injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 25 % injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
| Pre-biopsy localisation of breast lesion using dye |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Pre-biopsy localization of breast lesion using spot method |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Pre-biopsy localisation of breast lesion using double dye method |
Using substance (attribute) |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
3 |
| Intrathecal injection of radiological dye |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Injection of dye into breast using ultrasound guidance (procedure) |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye introduction |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Injection of dye into breast using ultrasound guidance (procedure) |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagn. dye introduction NOS |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye - subcutaneous |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Diagnostic dye introduction |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Intrathecal injection of radiological dye |
Direct substance |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| allergi over for diagnostisk farvestof |
Causative agent |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Intrathecal injection of radiological dye |
Direct substance |
False |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Localization of lesion with diagnostic dye using ultrasonographic guidance (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Cone beam CT guided localisation of lesion with diagnostic dye |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Localization of lesion with diagnostic dye using fluoroscopic guidance (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Localization of sentinel lymph node using diagnostic dye (procedure) |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Pre-biopsy localisation of breast lesion using dye |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Pre-biopsy localization of breast lesion using spot method |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
2 |
| Pre-biopsy localisation of breast lesion using double dye method |
Using substance (attribute) |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
1 |
| Isosulfan blue (substance) |
Is a |
True |
Diagnostic dye (substance) |
Inferred relationship |
Some |
|
FHIR